Ocugen, Inc. (OCGN) vs Prelude Therapeutics Incorporated (PRLD)
Ocugen, Inc. and Prelude Therapeutics Incorporated are both Biotechnology companies. Ocugen, Inc. and Prelude Therapeutics Incorporated are of similar size ($339.1M and $318.4M). Prelude Therapeutics Incorporated has the higher net margin (−269.8% vs −1,786.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Prelude Therapeutics Incorporated leads on 10 and Ocugen, Inc. on 3.
Valuation
Profitability
| Metric | OCGN | PRLD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (1,504.43%) | (300.56%) | 0.00% |
| Net margin | (1,786.27%) | (269.75%) | 0.00% |
| Free cash flow margin | (1,332.36%) | (148.30%) | 0.00% |
| Return on equity | 1,211.66% | (57.73%) | (57.72%) |
| Return on assets | (92.03%) | (39.76%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack